Unlocking the power of short-chain fatty acids in ameliorating intestinal mucosal immunity: a new porcine nutritional approach
- PMID: 39286812
- PMCID: PMC11402818
- DOI: 10.3389/fcimb.2024.1449030
Unlocking the power of short-chain fatty acids in ameliorating intestinal mucosal immunity: a new porcine nutritional approach
Abstract
Short-chain fatty acids (SCFAs), a subset of organic fatty acids with carbon chains ranging from one to six atoms in length, encompass acetate, propionate, and butyrate. These compounds are the endproducts of dietary fiber fermentation, primarily catalyzed by the glycolysis and pentose phosphate pathways within the gut microbiota. SCFAs act as pivotal energy substrates and signaling molecules in the realm of animal nutrition, exerting a profound influence on the intestinal, immune system, and intestinal barrier functions. Specifically, they contibute to 60-70% of the total energy requirements in ruminants and 10-25% in monogastric animals. SCFAs have demonstrated the capability to effectively modulate intestinal pH, optimize the absorption of mineral elements, and impede pathogen invasion. Moreover, they enhance the expression of proteins associated with intestinal tight junctions and stimulate mucus production, thereby refining intestinal tissue morphology and preserving the integrity of the intestinal structure. Notably, SCFAs also exert anti-inflammatory properties, mitigating inflammation within the intestinal epithelium and strengthening the intestinal barrier's defensive capabilities. The present review endeavors to synthesize recent findings regarding the role of SCFAs as crucial signaling intermediaries between the metabolic activities of gut microbiota and the status of porcine cells. It also provides a comprehensive overview of the current literature on SCFAs' impact on immune responses within the porcine intestinal mucosa.
Keywords: gut microbiota; intestinal mucosal immunity; nutrition; porcine; short-chain fatty acids.
Copyright © 2024 Liu, Lu, Wang, Yu, He and Dong.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
Short chain fatty acids and its producing organisms: An overlooked therapy for IBD?EBioMedicine. 2021 Apr;66:103293. doi: 10.1016/j.ebiom.2021.103293. Epub 2021 Apr 1. EBioMedicine. 2021. PMID: 33813134 Free PMC article. Review.
-
Exploring the Molecular Mechanisms Underlying the Protective Effects of Microbial SCFAs on Intestinal Tolerance and Food Allergy.Front Immunol. 2020 Jun 16;11:1225. doi: 10.3389/fimmu.2020.01225. eCollection 2020. Front Immunol. 2020. PMID: 32612610 Free PMC article. Review.
-
Short-chain fatty acids affect the development of inflammatory bowel disease through intestinal barrier, immunology, and microbiota: A promising therapy?J Gastroenterol Hepatol. 2022 Sep;37(9):1710-1718. doi: 10.1111/jgh.15970. Epub 2022 Aug 5. J Gastroenterol Hepatol. 2022. PMID: 35906780 Review.
-
Short-chain fatty acids augment rat duodenal mucosal barrier function.Exp Physiol. 2017 Jul 1;102(7):791-803. doi: 10.1113/EP086110. Epub 2017 May 25. Exp Physiol. 2017. PMID: 28436589
-
Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases.Front Immunol. 2019 Mar 11;10:277. doi: 10.3389/fimmu.2019.00277. eCollection 2019. Front Immunol. 2019. PMID: 30915065 Free PMC article. Review.
Cited by
-
The Detrimental Impact of Ultra-Processed Foods on the Human Gut Microbiome and Gut Barrier.Nutrients. 2025 Feb 28;17(5):859. doi: 10.3390/nu17050859. Nutrients. 2025. PMID: 40077728 Free PMC article. Review.
-
Unraveling the composition and function of pig gut microbiome from metagenomics.Anim Microbiome. 2025 Jun 4;7(1):60. doi: 10.1186/s42523-025-00419-7. Anim Microbiome. 2025. PMID: 40468444 Free PMC article. Review.
References
-
- Alva-Murillo N., Ochoa-Zarzosa A., López-Meza J. E. (2012). Short chain fatty acids (propionic and hexanoic) decrease Staphylococcus aureus internalization into bovine mammary epithelial cells and modulate antimicrobial peptide expression. Vet. Microbiol. 155, 324–331. doi: 10.1016/j.vetmic.2011.08.025 - DOI - PubMed
-
- Anshory M., Effendi R. M. R. A., Kalim H., Dwiyana R. F., Suwarsa O., Nijsten T. E. C., et al. . (2023). Butyrate properties in immune-related diseases: friend or foe? Fermentation 9 (3), 205. doi: 10.3390/fermentation9030205 - DOI
-
- Asadpoor M., Ithakisiou G.-N., Henricks P. A. J., Pieters R., Folkerts G., Braber S. (2021). Non-digestible oligosaccharides and short chain fatty acids as therapeutic targets against enterotoxin-producing bacteria and their toxins. Toxins (Basel) 13, 175. doi: 10.3390/toxins13030175 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources